# Harbour BioMed Announces NMPA Acceptance of IND Application for Its First AI-Enabled Drug Candidate LET003 for the Treatment of Overweight or Obesity

- Source: PR Newswire M&A
- Published: 2026-11-19T00:01:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/harbour-biomed-announces-nmpa-acceptance-of-ind-application-for-its-first-ai-enabled-drug-candidate-let003-for-the-treatment-of-overweight-or-obesity-302944581.html
- Canonical: https://groundlevelnews.com/story/harbour-biomed-announces-nmpa-acceptance-of-ind-application-for-its-fi-203c1f/

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Nov. 18, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
